Phase II trial of chemoradiotherapy with S‐1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706)

Publisher： John Wiley & Sons Inc

E-ISSN： 1349-7006|106|6|726-733

ISSN： 1347-9032

Source： Cancer Science, Vol.106, Iss.6, 2015-06, pp. : 726-733

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I/II trial of chemoradiotherapy with concurrent S‐1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604)

By  

Cancer Science, Vol. 106, Iss. 10, 2015-10 ,pp. : 1414-1420

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomized study of low‐dose versus standard‐dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303)

By  

Cancer Science, Vol. 106, Iss. 4, 2015-04 ,pp. : 407-412

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomized phase II/III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS‐PC Study

By  

Cancer Science, Vol. 106, Iss. 7, 2015-07 ,pp. : 883-890

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neutron and Neutron-Photon Therapy for Head and Neck Cancer

By  

Advanced Materials Research, Vol. 2015, Iss. 1084, 2015-02 ,pp. : 409-412

Trans Tech Publications

Access to resources Recommend Favorite

Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non‐small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX‐Lung 3

By  

Cancer Science, Vol. 1347-9032, Iss. 9, 2015-09 ,pp. : 1202-1211

John Wiley & Sons Inc

Access to resources Recommend Favorite